Mankind Pharma Assigned 'Leader' Category ESG Rating of 68.21 by Niche99
Mankind Pharma Ltd 路 Others (Uncategorized) 路 16 Sept 2026, 1:20 am
Mankind Pharma Assigned 'Leader' Category ESG Rating of 68.21 by Niche99 Niche99 ESG Ratings, a SEBI-registered Category II ESG Rating Provider, assigned Mankind Pharma Limited an ESG rating of 68.21 under the "Leader" category based on publicly available disclosures for FY'26. The company noted that the evaluation was prepared independently by Niche99 and was not an engaged rating assignment.
Original exchange filing (PDF)
More announcements from Mankind Pharma Ltd
- Please find attached intimation regarding change in Corporate Office Address of RTA 路 13 Nov 2026
- Please find attached Intimation of participation in the Investor Conference 路 06 Nov 2026
- Please find attached intimation regarding ESG Rating 路 05 Nov 2026
- Intimation of participation in the Investor Conference. 路 03 Nov 2026
- Please find attached transcript of the Earnings Conference Call for Q2 & H1 FY27 路 30 Oct 2026
- Please find attached intimation regarding re-affirmation/withdrawl of Credit Rating by CRISIL 路 30 Oct 2026
- In continuation of our earlier intimation dated October 22, 2026 please find attached the Investor Presentation to be made during the said Analyst / Institutional Investors meet 路 27 Oct 2026
- Please find attached link for audio recording of the Investor Conference Call held on October 26, 2026 路 27 Oct 2026
